The global spine biologics market is expected to reach $2.7 billion by 2024, increasing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.
Here are 18 key market players:
1. Arthrex
2. Cesca Therapeutics
3. DePuy Synthes
4. DMP Spine
5. Exactech
6. K2M
7. Lattice Biologics
8. Medtronic
9. Nuo Therapeutics
10. NuTech
11. NuVasive
12. Orthofix Holdings
13. Regen Lab SA
14. RTI Surgical
15. Stryker
16. Wright Medical Technology
17. Xtant Medical Holdings
18. Zimmer Biomet